Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma

Saved in:
Bibliographic Details
Main Authors: Marek Pasek, Eva Sticová, Emanuel Marques, Vojtěch Tretera, Petr Arenberger, Monika Arenbergerová
Format: Article
Language:English
Published: Mattioli1885 2025-01-01
Series:Dermatology Practical & Conceptual
Subjects:
Online Access:https://dpcj.org/index.php/dpc/article/view/4967
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540715987501056
author Marek Pasek
Eva Sticová
Emanuel Marques
Vojtěch Tretera
Petr Arenberger
Monika Arenbergerová
author_facet Marek Pasek
Eva Sticová
Emanuel Marques
Vojtěch Tretera
Petr Arenberger
Monika Arenbergerová
author_sort Marek Pasek
collection DOAJ
format Article
id doaj-art-2a381384aa514d828c16d50f84320760
institution Kabale University
issn 2160-9381
language English
publishDate 2025-01-01
publisher Mattioli1885
record_format Article
series Dermatology Practical & Conceptual
spelling doaj-art-2a381384aa514d828c16d50f843207602025-02-04T15:41:26ZengMattioli1885Dermatology Practical & Conceptual2160-93812025-01-0115110.5826/dpc.1501a4967Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic MelanomaMarek Pasek0https://orcid.org/0009-0000-0875-8332Eva Sticová1https://orcid.org/0000-0003-2486-6266Emanuel Marques2https://orcid.org/0000-0003-1451-6115Vojtěch Tretera3https://orcid.org/0009-0002-5557-6026Petr Arenberger4https://orcid.org/0000-0002-4800-5877Monika Arenbergerová5https://orcid.org/0000-0002-7919-9619Department of Dermatology and Venereology, Third School of Medicine, Charles UniversityDepartment of Pathology, Third Faculty of Medicine, Charles University, and Královské Vinohrady University Hospital, Prague, Czech Republic Department of Dermatology and Venereology, St. Joseph Local Health Unit, Lisbon, Portugal and Department of Dermatology and Venereology, NOVA Medical School, NOVA University Lisbon, PortugalDepartment of Dermatology and Venereology, Third Faculty of Medicine, Charles University, and Královské Vinohrady University Hospital, Prague, Czech RepublicDepartment of Dermatology and Venereology, Third Faculty of Medicine, Charles University, and Královské Vinohrady University Hospital, Prague, Czech RepublicDepartment of Dermatology and Venereology, Third Faculty of Medicine, Charles University, and Královské Vinohrady University Hospital, Prague, Czech Republichttps://dpcj.org/index.php/dpc/article/view/4967melanoma, anti-PD-1, anti-LAG-3, adverse events
spellingShingle Marek Pasek
Eva Sticová
Emanuel Marques
Vojtěch Tretera
Petr Arenberger
Monika Arenbergerová
Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma
Dermatology Practical & Conceptual
melanoma, anti-PD-1, anti-LAG-3, adverse events
title Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma
title_full Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma
title_fullStr Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma
title_full_unstemmed Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma
title_short Lichen Planus-Like Exanthema Induced by Anti-PD-1 and Anti-LAG-3 Combination Immunotherapy Could Potentially Predict the Treatment Response in Metastatic Melanoma
title_sort lichen planus like exanthema induced by anti pd 1 and anti lag 3 combination immunotherapy could potentially predict the treatment response in metastatic melanoma
topic melanoma, anti-PD-1, anti-LAG-3, adverse events
url https://dpcj.org/index.php/dpc/article/view/4967
work_keys_str_mv AT marekpasek lichenplanuslikeexanthemainducedbyantipd1andantilag3combinationimmunotherapycouldpotentiallypredictthetreatmentresponseinmetastaticmelanoma
AT evasticova lichenplanuslikeexanthemainducedbyantipd1andantilag3combinationimmunotherapycouldpotentiallypredictthetreatmentresponseinmetastaticmelanoma
AT emanuelmarques lichenplanuslikeexanthemainducedbyantipd1andantilag3combinationimmunotherapycouldpotentiallypredictthetreatmentresponseinmetastaticmelanoma
AT vojtechtretera lichenplanuslikeexanthemainducedbyantipd1andantilag3combinationimmunotherapycouldpotentiallypredictthetreatmentresponseinmetastaticmelanoma
AT petrarenberger lichenplanuslikeexanthemainducedbyantipd1andantilag3combinationimmunotherapycouldpotentiallypredictthetreatmentresponseinmetastaticmelanoma
AT monikaarenbergerova lichenplanuslikeexanthemainducedbyantipd1andantilag3combinationimmunotherapycouldpotentiallypredictthetreatmentresponseinmetastaticmelanoma